{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T05:31:34Z","timestamp":1793770294583,"version":"4.6.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.lfs.2026.124743","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T09:42:20Z","timestamp":1792230140000},"page":"124743","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Dapagliflozin alleviates CYH33-induced hyperglycemia and preserves antitumor immunity against ovarian cancer in type 1 diabetic mice"],"prefix":"10.1016","volume":"406","author":[{"given":"Jiaqi","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linghua","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2026.124743_bb0005","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.semcancer.2019.07.009","article-title":"PI3K\/Akt\/mTOR inhibitors in cancer: at the bench and bedside","volume":"59","author":"Alzahrani","year":"2019","journal-title":"Semin. Cancer Biol."},{"issue":"3","key":"10.1016\/j.lfs.2026.124743_bb0010","first-page":"573","article-title":"Targeting the PI3K\/AKT\/mTOR pathway in epithelial ovarian cancer, therapeutic treatment options for platinum-resistant ovarian cancer","volume":"4","author":"Rinne","year":"2021","journal-title":"Cancer Drug Resist."},{"issue":"9","key":"10.1016\/j.lfs.2026.124743_bb0015","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41580-019-0129-z","article-title":"PI3K isoforms in cell signalling and vesicle trafficking","volume":"20","author":"Bilanges","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.lfs.2026.124743_bb0020","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","article-title":"The PI3K pathway in human disease","volume":"170","author":"Fruman","year":"2017","journal-title":"Cell"},{"issue":"41","key":"10.1016\/j.lfs.2026.124743_bb0025","doi-asserted-by":"crossref","first-page":"5486","DOI":"10.1038\/onc.2008.244","article-title":"Class I PI3K in oncogenic cellular transformation","volume":"27","author":"Zhao","year":"2008","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.lfs.2026.124743_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12010093","article-title":"PIK3CA gene mutations in solid malignancies: association with clinicopathological parameters and prognosis","volume":"12","author":"Alqahtani","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.lfs.2026.124743_bb0035","article-title":"Artificial intelligence-based models enabling accurate diagnosis of ovarian cancer using laboratory tests in China: a multicentre, retrospective cohort study","volume":"6","author":"Cai","year":"2024","journal-title":"Lancet Digit. Health"},{"issue":"3","key":"10.1016\/j.lfs.2026.124743_bb0040","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.bpobgyn.2011.12.005","article-title":"Epithelial ovarian cancer","volume":"26","author":"Ng","year":"2012","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.lfs.2026.124743_bb0045","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.semcancer.2019.05.012","article-title":"Role of the PI3K\/AKT\/mTOR signaling pathway in ovarian cancer: biological and therapeutic significance","volume":"59","author":"Ediriweera","year":"2019","journal-title":"Semin. Cancer Biol."},{"issue":"4","key":"10.1016\/j.lfs.2026.124743_bb0050","doi-asserted-by":"crossref","DOI":"10.3892\/or.2022.8293","article-title":"Molecular mechanisms of platinum-based chemotherapy resistance in ovarian cancer (review)","volume":"47","author":"Yang","year":"2022","journal-title":"Oncol. Rep."},{"issue":"10","key":"10.1016\/j.lfs.2026.124743_bb0055","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/s41419-018-1025-8","article-title":"IGF1R upregulation confers resistance to isoform-specific inhibitors of PI3K in PIK3CA-driven ovarian cancer","volume":"9","author":"Zorea","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2026.124743_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102021","article-title":"Targeting the PI3K pathway and DNA damage response as a therapeutic strategy in ovarian cancer","volume":"86","author":"Huang","year":"2020","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.lfs.2026.124743_bb0065","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ygyno.2024.02.029","article-title":"Alpelisib for PIK3CA-mutated advanced gynecological cancers: first clues of clinical activity","volume":"183","author":"Passarelli","year":"2024","journal-title":"Gynecol. Oncol."},{"issue":"11","key":"10.1016\/j.lfs.2026.124743_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijgc.2025.102737","article-title":"Global phase II study of risovalisib, a selective PI3K\u03b1 inhibitor, as monotherapy in patients with recurrent\/persistent ovarian clear cell carcinoma harboring PIK3CA hotspot mutations","volume":"35","author":"Wu","year":"2025","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"20","key":"10.1016\/j.lfs.2026.124743_bb0075","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1056\/NEJMoa1813904","article-title":"Alpelisib for PIK3CA-mutated, hormone receptor-positive advanced breast cancer","volume":"380","author":"Andre","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"7719","key":"10.1016\/j.lfs.2026.124743_bb0080","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41586-018-0343-4","article-title":"Suppression of insulin feedback enhances the efficacy of PI3K inhibitors","volume":"560","author":"Hopkins","year":"2018","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.lfs.2026.124743_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22073464","article-title":"PI3K inhibitors in cancer: clinical implications and adverse effects","volume":"22","author":"Mishra","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2026.124743_bb0090","doi-asserted-by":"crossref","DOI":"10.1177\/15347354211073163","article-title":"Management of phosphatidylinositol-3-kinase inhibitor-associated hyperglycemia","volume":"21","author":"Goncalves","year":"2022","journal-title":"Integr. Cancer Ther."},{"issue":"1","key":"10.1016\/j.lfs.2026.124743_bb0095","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41523-024-00613-x","article-title":"Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique","volume":"10","author":"Gallagher","year":"2024","journal-title":"NPJ Breast Cancer"},{"issue":"1","key":"10.1016\/j.lfs.2026.124743_bb0100","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12943-024-02023-w","article-title":"Regulatory mechanisms of PD-1\/PD-L1 in cancers","volume":"23","author":"Lin","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.lfs.2026.124743_bb0105","article-title":"The role of PD-1 signaling in health and immune-related diseases","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Immunol."},{"issue":"7718","key":"10.1016\/j.lfs.2026.124743_bb0110","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","article-title":"Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response","volume":"560","author":"Chen","year":"2018","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.lfs.2026.124743_bb0115","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003093","article-title":"PI3Kalpha inhibitor CYH33 triggers antitumor immunity in murine breast cancer by activating CD8(+)T cells and promoting fatty acid metabolism","volume":"9","author":"Sun","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.lfs.2026.124743_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112913","volume":"209","author":"Xiang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.lfs.2026.124743_bb0125","doi-asserted-by":"crossref","first-page":"7012","DOI":"10.1038\/s41467-022-34782-9","article-title":"First-in-human phase Ia study of the PI3Kalpha inhibitor CYH33 in patients with solid tumors","volume":"13","author":"Wei","year":"2022","journal-title":"Nat. Commun."},{"issue":"Suppl. 1","key":"10.1016\/j.lfs.2026.124743_bb0130","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.2337\/dc21-S002","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2021","volume":"44","author":"American Diabetes A","year":"2021","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.lfs.2026.124743_bb0135","doi-asserted-by":"crossref","first-page":"E1323","DOI":"10.1152\/ajpendo.90617.2008","article-title":"Evaluating the glucose tolerance test in mice","volume":"295","author":"Andrikopoulos","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2026.124743_bb0140","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1743-7075-9-11","article-title":"Diet supplementation with green tea extract epigallocatechin gallate prevents progression to glucose intolerance in db\/db mice","volume":"9","author":"Ortsater","year":"2012","journal-title":"Nutr. Metab. (Lond.)"},{"issue":"2","key":"10.1016\/j.lfs.2026.124743_bb0145","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic Clin. Pharm."},{"issue":"1","key":"10.1016\/j.lfs.2026.124743_bb0150","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41392-023-01359-x","article-title":"Intact regulation of G1\/S transition renders esophageal squamous cell carcinoma sensitive to PI3Kalpha inhibitors","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.lfs.2026.124743_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2015.00181","article-title":"What is synergy? The Saariselka agreement revisited","volume":"6","author":"Tang","year":"2015","journal-title":"Front. Pharmacol."},{"issue":"7","key":"10.1016\/j.lfs.2026.124743_bb0160","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/jnci\/89.7.512","article-title":"Regression of established tumors expressing P-glycoprotein by combinations of adriamycin, cyclosporin derivatives, and MRK-16 antibodies","volume":"89","author":"Watanabe","year":"1997","journal-title":"J. Natl. Cancer Inst."},{"issue":"5","key":"10.1016\/j.lfs.2026.124743_bb0165","first-page":"375","article-title":"Nickel and chromium levels in the saliva and serum of patients with fixed orthodontic appliances","volume":"71","author":"Agaoglu","year":"2001","journal-title":"Angle Orthod."},{"issue":"1","key":"10.1016\/j.lfs.2026.124743_bb0170","doi-asserted-by":"crossref","first-page":"H416","DOI":"10.1152\/ajpheart.00327.2002","article-title":"Isolation of interstitial fluid from rat mammary tumors by a centrifugation method","volume":"284","author":"Wiig","year":"2003","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"7","key":"10.1016\/j.lfs.2026.124743_bb0175","doi-asserted-by":"crossref","DOI":"10.1007\/s00262-026-04405-z","article-title":"Downregulation of ANKRD22 promotes ovarian cancer cell proliferation by enhancing the immunosuppressive capacity of M-MDSCs","volume":"75","author":"Chen","year":"2026","journal-title":"Cancer Immunol. Immunother."},{"issue":"5","key":"10.1016\/j.lfs.2026.124743_bb0180","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/ame2.12497","article-title":"Modified streptozotocin-induced diabetic model in rodents","volume":"7","author":"Lennikov","year":"2024","journal-title":"Anim. Model. Exp. Med."},{"issue":"3","key":"10.1016\/j.lfs.2026.124743_bb0185","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2337\/dc14-0666","article-title":"Dapagliflozin improves glycemic control and reduces body weight as add-on therapy to metformin plus sulfonylurea: a 24-week randomized, double-blind clinical trial","volume":"38","author":"Matthaei","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lfs.2026.124743_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.597675","article-title":"Inflammation and skeletal muscle wasting during cachexia","volume":"11","author":"Webster","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.lfs.2026.124743_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154324","article-title":"Dapagliflozin promotes beta cell regeneration by inducing pancreatic endocrine cell phenotype conversion in type 2 diabetic mice","volume":"111","author":"Wei","year":"2020","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.lfs.2026.124743_bb0200","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10549-024-07405-8","article-title":"SGLT2 inhibition improves PI3K\u03b1 inhibitor-induced hyperglycemia: findings from preclinical animal models and from patients in the BYLieve and SOLAR-1 trials","volume":"208","author":"Borrego","year":"2024","journal-title":"Breast Cancer Res. Treat."},{"issue":"13","key":"10.1016\/j.lfs.2026.124743_bb0205","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1200\/JCO.2017.72.7107","article-title":"Phosphatidylinositol 3-kinase alpha-selective inhibition with Alpelisib (BYL719) in PIK3CA-altered solid tumors: results from the first-in-human study","volume":"36","author":"Juric","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.lfs.2026.124743_bb0210","doi-asserted-by":"crossref","DOI":"10.2337\/db23-0553","article-title":"Gut microbiota-tryptophan metabolism-GLP-1 axis participates in \u03b2-cell regeneration induced by Dapagliflozin","volume":"73","author":"Jiang","year":"2024","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.lfs.2026.124743_bb0215","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1210\/jc.2014-1425","article-title":"beta-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment","volume":"99","author":"Halban","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.lfs.2026.124743_bb0220","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.jcmgh.2022.07.008","article-title":"Hyperglycemia enhances immunosuppression and aerobic glycolysis of pancreatic cancer through upregulating Bmi1-UPF1-HK2 pathway","volume":"14","author":"Wu","year":"2022","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.lfs.2026.124743_bb0225","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-011310","article-title":"Hyperglycemia induces an immunosuppressive microenvironment in colorectal cancer liver metastases by recruiting peripheral blood monocytes through the CCL3-CCR1 axis","volume":"13","author":"Peng","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.lfs.2026.124743_bb0230","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-023-04302-4","article-title":"High glucose-upregulated PD-L1 expression through RAS signaling-driven downregulation of PTRH1 leads to suppression of T cell cytotoxic function in tumor environment","volume":"21","author":"Gao","year":"2023","journal-title":"J. Transl. Med."},{"issue":"5","key":"10.1016\/j.lfs.2026.124743_bb0235","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41416-022-02106-9","article-title":"Hyperglycaemia induces metabolic reprogramming into a glycolytic phenotype and promotes epithelial-mesenchymal transitions via YAP\/TAZ-Hedgehog signalling axis in pancreatic cancer","volume":"128","author":"Liu","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.lfs.2026.124743_bb0240","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.pharmthera.2018.11.004","article-title":"Altered cancer metabolism in mechanisms of immunotherapy resistance","volume":"195","author":"Ramapriyan","year":"2019","journal-title":"Pharmacol. Ther."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320526005527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320526005527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T05:18:17Z","timestamp":1793769497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320526005527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":48,"alternative-id":["S0024320526005527"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2026.124743","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dapagliflozin alleviates CYH33-induced hyperglycemia and preserves antitumor immunity against ovarian cancer in type 1 diabetic mice","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2026.124743","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124743"}}